These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23262208)

  • 1. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
    Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
    Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.
    Chen CH; Shyu MK; Wang SW; Chou CH; Huang MJ; Lin TC; Chen ST; Lin HH; Huang MC
    Gynecol Oncol; 2016 Jan; 140(1):131-7. PubMed ID: 26616226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway.
    Tsai PC; Hsieh CY; Chiu CC; Wang CK; Chang LS; Lin SR
    Toxicon; 2012 Oct; 60(5):734-43. PubMed ID: 22683533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
    Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
    BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylation.
    Luwor RB; Chin X; McGeachie AB; Robinson PJ; Zhu HJ
    Growth Factors; 2012 Aug; 30(4):220-9. PubMed ID: 22574813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
    Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
    Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
    Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
    Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
    Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat3 activation in human endometrial and cervical cancers.
    Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
    Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
    Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
    Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR/mitogen-activated protein kinase signaling pathway.
    Ai Z; Wang J; Wang Y; Lu L; Tong J; Teng Y
    Cancer; 2010 Aug; 116(15):3603-13. PubMed ID: 20564127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.